Latest filing published 11 Mar 2024 for UNITED THERAPEUTICS Corp, €1.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Katherine J. Klein discloses dealings in UNITED THERAPEUTICS Corp to SEC (Form 4). Over a trading history stretching from 26 June 2021 to 8 March 2024, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 11 March 2024 with an option exercise (€1.1M) in UNITED THERAPEUTICS Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations